Search - tctmd.com

Displaying 141 - 160 of 400

Sort: Relevancy | Date

Presentation

Antithrombotic Therapy and CV Outcomes After TAVR in A-fib Patients

August 20, 2019

Presentation TVT 2019

Impact of Pre-Existing Atrial Fibrillation on Clinical Outcomes in Patients Who Underwent Balloon-Expandable Transcatheter Aortic Valve Replacement

Presenter: Hyungdon Kook

June 14, 2019

Presentation TVT 2019

Operator and Institutional Requirements for LAA Occlusion for Non-Valvular Atrial Fibrillation

Presenter: Hemal Gada

June 14, 2019

Presentation TVT 2019

Critical Appraisal of the Advantages and Limitations of Warfarin, NOACs, and Ablation in Patients With Non-Valvular Atrial Fibrillation

Presenter: DJ Lakkireddy

June 13, 2019

Presentation ARCH 2019

A Glimpse at Boston Scientific’s Structural Heart Therapies PortfolioAdvanced Revascularization Chapter XII

Presenter: David G. Rizik

April 11, 2019

Presentation ARCH 2019

Practical Education: Tricks and Tools to Facilitate AF Ablation

Presenter: Sandeep Gautam

April 10, 2019

Presentation ARCH 2019

Persistent AF: Lessons Learned from 30 years of Surgical Experience

Presenter: Ralph J. Damiano

April 10, 2019

Presentation ARCH 2019

Innovation in AF Ablation: Better Methods / Techniques for Successful Ablation

Presenter: Andrea Natale

April 10, 2019

Presentation ARCH 2019

Case Presentation: Atrial Fibrillation

Presenter: Curtis M. Steyers III

April 10, 2019

Presentation ARCH 2019

CABANA What Did We Learn? How Can We Do Better?

Presenter: Marye J. Gleva

April 10, 2019

Presentation SIF 2019

Pharmacologic Strategies for Managing Patients with Atrial Fibrillation Undergoing Coronary Intervention

Presenter: Michael A. Kutcher

March 28, 2019

Presentation ACC 2019

Apixaban vs VKA and Aspirin vs Placebo in Patients with Atrial Fibrillation and ACS/PCI: The AUGUSTUS Trial

Presenter: Renato Lopes

March 18, 2019

Presentation

Continued vs Interrupted Oral Anticoagulation During Transfemoral TAVR and Impact of Postop Anticoagulant Management in A-fib Patients

January 09, 2019

Presentation AHA 2018

REDUCE-IT Trial: Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial

Presenter: Deepak L Bhatt

November 16, 2018

Alert-Based Computerized Decision Support to Increase Anticoagulation Prescription Prevents Stroke and Myocardial Infarction in High-Risk Hospitalized Patients with Atrial Fibrillation: A Randomized, Controlled Trial (AF-ALERT)

Presentation AHA 2018

High-Risk Hospitalized Patients with Atrial Fibrillation: A Randomized, Controlled Trial (AF-ALERT)

Presenter: Gregory Piazza

November 11, 2018

Presentation

Atrial Fibrillation: What Is the Best Approach to Treat and Control? A Practical Approach

Presenter: T. Jared Bunch

October 12, 2018

Presentation TCT Abstracts Posters 2018

Comparison of clinical outcomes between left atrial appendage occlusion with dual antiplatelet therapy versus conventional antithrombotic therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation

Presenter: Hyungdon Kook

September 25, 2018

Presentation TCT 2018

LAA Closure: Challenging Case Vignettes

Presenter: Saibal Kar, Horst Sievert, Philippe Garot, Jan Kovac, Ashish Pershad, Ramon Quesada, Peter B. Sick, Brian K. Whisenant

September 24, 2018

Presentation TCT 2018

The Big Picture: Choosing the Right Device for the Right Anatomy

Presenter: Saibal Kar, Horst Sievert

September 24, 2018

Presentation TCT 2018

Epicardial LAA closure: From Surgical Results to Transpericardial Applications

Presenter: Saibal Kar, Horst Sievert, Krzysztof Bartus

September 24, 2018

Advertisement

Antithrombotic Therapy and CV Outcomes After TAVR in A-fib Patients

Impact of Pre-Existing Atrial Fibrillation on Clinical Outcomes in Patients Who Underwent Balloon-Expandable Transcatheter Aortic Valve Replacement

Operator and Institutional Requirements for LAA Occlusion for Non-Valvular Atrial Fibrillation

Critical Appraisal of the Advantages and Limitations of Warfarin, NOACs, and Ablation in Patients With Non-Valvular Atrial Fibrillation

A Glimpse at Boston Scientific’s Structural Heart Therapies PortfolioAdvanced Revascularization Chapter XII

Practical Education: Tricks and Tools to Facilitate AF Ablation

Persistent AF: Lessons Learned from 30 years of Surgical Experience

Innovation in AF Ablation: Better Methods / Techniques for Successful Ablation

Case Presentation: Atrial Fibrillation

CABANA What Did We Learn? How Can We Do Better?

Pharmacologic Strategies for Managing Patients with Atrial Fibrillation Undergoing Coronary Intervention

Apixaban vs VKA and Aspirin vs Placebo in Patients with Atrial Fibrillation and ACS/PCI: The AUGUSTUS Trial

Continued vs Interrupted Oral Anticoagulation During Transfemoral TAVR and Impact of Postop Anticoagulant Management in A-fib Patients

REDUCE-IT Trial: Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial

High-Risk Hospitalized Patients with Atrial Fibrillation: A Randomized, Controlled Trial (AF-ALERT)

Atrial Fibrillation: What Is the Best Approach to Treat and Control? A Practical Approach

Comparison of clinical outcomes between left atrial appendage occlusion with dual antiplatelet therapy versus conventional antithrombotic therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation

LAA Closure: Challenging Case Vignettes

The Big Picture: Choosing the Right Device for the Right Anatomy

Epicardial LAA closure: From Surgical Results to Transpericardial Applications

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content